Active Ingredient(s): Sermorelin, GHRH
FDA Approved: * December 28, 1990
Pharm Company: * SERONO
Category: Growth Hormone Treatment

Sermorelin acetate (INN; brand names Geref, Gerel), also known as GHRH (1-29), is a peptide analogue of growth hormone-releasing hormone (GHRH) which is used as a diagnostic agent to assess growth hormone (GH) secretion for the purpose of diagnosing growth hormone deficiency. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, thought to be the shortest fully functional fragment of GHRH.[1][2] See also List of g... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Popular Topics


Geref 200 , IV XI...